Filing Flows › QHSLab (USAQ) › Recalls, complaints & regulation
QHSLab (USAQ): clinical trials
QHSLab (USAQ) beyond its filings: 2 active clinical trials.
QHSLab's latest quarter
QHSLab, Q2 2026: revenue $847K (+40% year over year), operating margin 5.3%, net earnings $38K, operating cash flow −$8K. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does QHSLab have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.